N4 Pharma Plc (LON:N4P – Get Free Report)’s share price shot up 3% during mid-day trading on Thursday . The company traded as high as GBX 0.90 ($0.01) and last traded at GBX 0.85 ($0.01). 649,204 shares were traded during trading, a decline of 47% from the average session volume of 1,224,113 shares. The stock had previously closed at GBX 0.83 ($0.01).
N4 Pharma Trading Up 3.0 %
The stock has a 50 day simple moving average of GBX 0.74 and a 200-day simple moving average of GBX 0.84. The firm has a market capitalization of £2.28 million, a P/E ratio of -120.00 and a beta of -0.03. The company has a current ratio of 27.88, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Featured Articles
- Five stocks we like better than N4 Pharma
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Comprehensive PepsiCo Stock Analysis
- How to Calculate Stock Profit
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- What Are Dividends? Buy the Best Dividend Stocks
- 3 Steel Stocks Could Soar on New China Tariffs
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
